Main Menu
Main Menu
Watch webinars designed to help patients and caregivers learn about biomarker testing reports and enrolling in clinical trials. Each session offers expert knowledge and resources to help you ask questions and make informed decisions about your care.
With MyTumorID, I decide.
Date: Friday, Oct. 2, 2026
Time: 12 p.m. ET/9 a.m. PT
Join us for an educational MyTumorID webinar on October 2, 2026, to better understand your brain tumor biomarker testing report and what it may mean for your or your loved one’s brain tumor diagnosis. Our expert speaker will review what biomarker testing is and why it matters, then explain how to interpret the key sections of a biomarker report, common terms and findings, and how results may influence diagnosis, treatment planning, and clinical trial opportunities.
Date: Friday, Oct. 23, 2026
Time: 12 p.m. ET/9 a.m. PT
Attend this MyTumorID webinar on October 23, 2026, to learn from an expert in the field about how clinical trials work and the enrollment process. You’ll understand when and how clinical trials fit into brain tumor care, learn how biomarker testing can influence trial eligibility, and gain clarity around common misconceptions about trial safety and participation.
Length: 60min
Speakers: Serendipity Zapanta Rinonos, M.D., Ph.D.; Catherine (“Cathy”) Dearlove
This MyTumorID webinar features an expert in the field who explains what biomarker testing is, how it influences treatment planning and access to clinical trials, and why it matters. You’ll also hear from a patient about how biomarker testing results impacted her brain tumor experience.
Length: 60min
Speakers: Grace Tobin, M.D.; Tosha Besosa
In this webinar, hear from an expert in the field what clinical trials are, how they work, and why discussing them early in your treatment journey matters. You’ll gain practical tips for talking with your care team, learn how eligibility is determined, and hear a firsthand story from a member of the brain tumor community about navigating the clinical trial process.